Uncertainty At Sanofi Highlighted By Turmoil In Diabetes (Updated)
This article was originally published in The Pink Sheet Daily
Executive Summary
The French pharma scared investors this week with reports that there might be a CEO shake-up and that the long-booming diabetes franchise may be coming under pressure.